AWRE vs NBIX · rev $6.6M vs P/E 45, rev $1.77B
Aware Inc (AWRE) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Aware Inc (AWRE) is a software - application company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AWRE revenue for 2026-06-30 was $6.6M. Net income was -$6.0M. Revenue was up 96.1% from 2026-03-31 to 2026-06-30. AWRE currently screens at market cap $32.9M.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
AWRE currently screens at market cap $32.9M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the AWRE and NBIX stock pages for the full models.
Not investment advice.